Welcome to the regional pages for Thames Valley. Full details of national and local events are available on our events pages.
Upcoming branch events
Watch this space for news of upcoming branch events.
Past branch events
Visit the reports section to find out about past events the branch have run.
Visit the branch demographics to see the numbers and locations of our members (Dated January 2023).
Chair: Dr Kerry Broom CBiol FSRB
Vice Chair: Melanie Gelderd AMRSB
Secretary: Professor Ian Michael Hunneyball CBiol FRSB
Members: Stephen Lewis CBiol MRSB, Dr Ray Gibson CBiol FRSB, Dr John Grainger CBiol FRSB, Dr Mary Nnankya MRSB, Charles Okayo D'Harrington, Olivia Tomlinson, Dr Walter Lucchesi MRSB
Non-members are very welcome at all open Thames Valley meetings and events. If you or anyone you know, would like to receive regular email notices of our programme, please get in touch by emailing us at email@example.com
Meet the committee
Ray Gibson BSc PhD CBiol FRSB
Ray gained his BSc in botany and PhD in fungal physiology from the University of Nottingham where he held both College and University teaching posts before moving to a Post-Doctoral Research Fellowship on fungal viruses at Manchester University. In 1978 he joined a research group at the MOD Microbiological Research Establishment at Porton Down, Wiltshire, where he held a National Research & Development Corporation Senior Research Fellowship on the genetic manipulation of yeasts.
This led to a 25 years career with Cadbury Schweppes plc. First as a senior scientist at the PHLS Centre for applied Microbiology and Research, Porton Down, after which in 1985 he transferred to the company's Group Research Centre at the University of Reading, initially responsible for co-ordinating the Centre's research programme in biotechnology, microscopy and IT. In 1987 he became a founding director of Reading Scientific Services Ltd. As a wholly owned subsidiary of Cadbury Schweppes and now Kraft Foods, RSSL provides scientific and technical services to the Food & Pharmaceutical Industries. Ray was its Business & Strategic Development Director until his retirement in 2005.
Ray joined the Institute of Biology in 1982 and served on the Biologist Editorial Board 1987-90. He joined the Thames Valley branch committee in 1986 and was its vice chairman from 1998-2012, when he became branch chairman. He was elected to Fellowship of the Society of Biology in 2009.
John Grainger BSc PhD CBiol FRSB
John came to the University of Reading in 1957 to study for a PhD in microbiology following a BSc in bacteriology at the University of Birmingham. This was followed by appointment to the academic staff at Reading and development of research programmes in environmental microbiology encompassing studies on soil, agricultural waste and municipal refuse. His career progressed to a Senior Lectureship and then to Head of Department.
An interest in promoting microbiology in schools led to the founding of the National Centre for Biotechnology Education (NCBE) at Reading and activities abroad including membership of the management committee of the European Initiative for Biotechnology Education (EIBE). He was awarded the Peter Wildy Prize for Education in Microbiology by the Society for General Microbiology (SGM) in 2002. Now retired, John is a Visiting Research Fellow at Reading and a member of the Executive Committee of the Friends of the University. His work for schools continues, principally through being Chairman of the Microbiology in Schools Advisory Committee (MiSAC).
He joined the then IOB in 1980, was elected to Fellowship in 1990, is a past chairman of the Thames Valley branch and has served on Council.
Professor Ian Hunneyball BSc PhD FRSB
Ian has a BSc in Medical Biochemistry and a PhD in Experimental Pathology from the University of Birmingham. He continued his research at Birmingham with post-doctoral studies on the aetiology and pathogenesis of autoimmune disorders such as rheumatoid arthritis.
Ian is currently Senior Vice President, Programme Management & Clinical Operations for Evotec (UK) Ltd., based in Milton Park, Oxfordshire. In this role, he is part of a team establishing early clinical development activities within Evotec. His current focus is supporting the oncology research and development activities within Evotec and providing research and development advice to other in-house therapeutic areas as well as Evotec’s partners and external companies. Ian also holds the position of Honorary Professor in Biomedical Sciences at Sheffield Hallam University.
Prior to joining Evotec, Ian was Head of Research & Development for Entomed S. A., a French biotech company discovering and developing novel anti-microbial agents. Before that, he was Director of Research & Development for BASF Pharma in Nottingham. Previously he held various leadership roles with Boots Pharmaceuticals in the UK and USA, ultimately becoming global Director of Research and Development. Ian has over 40 years’ experience in the pharmaceutical industry covering all aspects of pharmaceutical research, development and regulatory activities across all therapeutic areas.
Ian joined the Institute of Biology as a Fellow in 1989 and became a member of the East Midlands Branch. On his return to the UK in 2003, he joined the Thames Valley Branch; he was elected Branch Secretary in 2019.
Stephen Lewis BSc MSc CBiol MRSB
Stephen gained his qualifications in biochemistry at the University of Wales (BSc) and the University of London (MSc). After working in fermentation research for antibiotic production, he moved into the field of contamination control and sterility control of processes in the medical device, pharmaceutical and biotechnology industries. This involved design and operation of clean rooms and assessment and elimination of contamination of environments, materials, services, equipment and personnel activities. It also included close involvement in documentation to support Good Manufacturing Practice (GMP), including control of Standard Operating Procedures (SOPs) and validation of systems.
Stephen has been a member of the Society for more than 20 years. Before joining the branch committee and subsequently becoming treasurer, he was on the committee of the Parenteral Society (now the Pharmaceutical and Healthcare Sciences Society) and also a member of its working party on standards for environmental contamination for processes and organiser of events including the Annual Conference and seminars.
Kerry Broom BSc DPhil CBiol FRSB
Kerry obtained a BSc at Brunel University in 1999 and a DPhil at Oxford University in 2004. Now a Principal Radiation Protection Scientist for Public Health England. Her job involves experimental research studies on the biological effects of non-ionising radiation. The research involves molecular biology techniques to study gene expression and immunohistochemistry to study the brain’s response to exposure to electromagnetic fields. Other research interests in the Nitric Oxide pathway in cells. She has supervised a number of PhD students jointly with the University of Oxford.
Kerry’s previous responsibilities have included scientific secretariat support to the Committee on Medical Aspects of Radiation in the Environment (COMARE). Kerry sat on the Institution of Engineering and Technology (IET) Biological Effects Policy Advisory Group which advised on the health effects of electromagnetic fields until 2016 when the committee closed. For the past 20 years, Kerry has worked with schools as a STEM Ambassador in the Oxfordshire area. She joined the branch committee in 2007 and was elected to Fellowship of the Society in 2010. She currently represents (jointly with Ray Gibson) the Thames Valley branch at the Society’s Branches Working Group.
Dr Mary Nnankya MRSB
Dr Mary Nnankya is a world class professional scientist with expertise in biotechnology and biochemical sciences applications to the research and development of therapeutics. She was awarded a PhD in Biological Sciences in March 1997 by the Dublin City University, Dublin, Eire; a MSc in 1993 and BSc in 1991 from the University of Paris 7, Jussieu, Paris, France.
She is highly proficient, with more than 30 years of international work experience in Europe, Africa and the USA working in the biotechnology sector of consultancy, private SME, academic, and institutional organisations in the use of multidisciplinary approaches in the research and development of therapeutics -drugs and vaccines- to provide accessible and sustainable solutions to treat, manage and control key global public health challenges at basic, preclinical and clinical stages of research and development including clinical trials Phases I/II and II/II.
Although she has worked mainly on infectious diseases including HIV/AIDS and HIV1 infection induced opportunistic infections and malaria; she has transferred knowledge and technology to working on infectious diseases along with comorbid diabetes, hypertension and dementia.
Having worked on the HIV pandemic between early 90s-2004 on the global coalition WHO/ANRS -France HIV1-V3Loop vaccine initiative and on antivirals in the private sector biotech SME; lately Mary and her clinical and public health colleagues at MBC have transferred to working on SARS-Cov-2 infection induced COVID-19 pandemic.
In addition to leading clinical research and development programs in management, directorship roles and/or as service providers or sponsor’s principal investigator, she has initiated various strategic and innovative projects in R&D, strategic partnerships and collaborations, a treatment clinic, she is a contributor to global outreach education programs in science & technology and public health, online platform science communications and the promotion of the use of evidence-based science and technology and has 5 languages of communication.
She has served as chair, secretary, treasurer or ordinary committee member on learned society and community organisations including SCI, and organised several successful educational, CPD and networking events and conferences with organising committee colleagues.
Dr Walter Lucchesi MRSB
Walter is a lecturer at Royal Holloway University of London with a great passion for outreach and scientific communication.
Walter obtained a degree in molecular biology from the University of Florence, in the now “feeling-so-far” 2000, and a PhD in virology from Imperial College London in 2008. Walter then spent 6 years as a post-doctoral researcher at the Institute of Psychiatry, King’s College London, studying the mechanisms of memory formation in health and disease, using both in vivo and ex vivo models.
His publication output is largely based on laboratory research but recently, he has developed a keen interest in the application of different teaching methods and the related pedagogical research. Walter is a very sociable character and loves sharing ideas and projects with colleagues and like-minded.
During the 2020 pandemic Walter has developed an outreach project with approximately 20 academics from all over the world, which have been appreciated by the public, leading to a Facebook page with 160k followers and a YouTube channel with over 3k followers.
Charles Okayo D'Harrington
Charles earned a BSc in Food Science & Technology from Egerton University in 2017 and an MSc from the University of Bath in 2020. At Oxford Biomedica, where he currently works as a bioassay scientist, he performs bioassays and analyses the results to determine the identification, safety, purity, quality, and functionality of finished and in-progress cell and gene therapy products.
Charles has previously worked for three years in the food and beverage industry in a variety of roles, including as a B2C product developer, a B2B product developer, and a consultant. During this time, he has helped both domestic and foreign companies with the discovery, development, manufacture, and marketing of their novel products as well as the resolution of quality-related issues with their existing products.
Charles has experience in a variety of sectors, and his long-term goals in business and research are to combine his love of artificial intelligence and machine learning with his knowledge and experience in the biopharmaceuticals and food and beverage industries to create prophylactic and therapeutic products that push the boundaries of precision health technology while also raising industry standards for functional foods. His goal is to make it possible for people to turn 150 and still appear like they are in their fifties.